News
Academy
Publications
Media
Conferences
Columns
Resources
Events
Subscribe
Event Calendar

Lawrence Grylack, MD

Articles by Lawrence Grylack, MD

Regulatory Update on Risk Evaluation and Mitigation Strategies (REMS)

ByLawrence Grylack, MD

October 25th 2010

Applied Clinical Trials

Latest Updated Articles

Regulatory Update on Risk Evaluation and Mitigation Strategies (REMS)
October 25th 2010

Trending on Applied Clinical Trials Online

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma